Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
255M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$344M
-
Value change
-
-$1.11M
-
Put/Call ratio
-
0.11
-
Number of buys
-
44
-
Number of sells
-
-58
-
Price
-
$1.35
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2025
147 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2025.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 255M shares
of 363M outstanding shares and own 70.24% of the company stock.
Largest 10 shareholders include Artal Group S.A. (136M shares), Siren, L.L.C. (38.9M shares), FMR LLC (38.7M shares), VANGUARD GROUP INC (9.52M shares), MILLENNIUM MANAGEMENT LLC (3.83M shares), BlackRock, Inc. (3.39M shares), Sessa Capital IM, L.P. (3M shares), CITADEL ADVISORS LLC (2.63M shares), CIBC Private Wealth Group LLC (2.4M shares), and GEODE CAPITAL MANAGEMENT, LLC (2.4M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.